Edit
Claris Lifesciences Limited
http://www.clarislifesciences.com/global/index.htmlLast activity: 22.05.2015
Active
Claris Ltd. (Claris) is a holding company established with a long-term objective of diversifying to multiple businesses, driven by the spirit of innovation & desire to make sustainable impact.
Powered by experience in building large scale global healthcare businesses from scratch, efficiently & quickly, Claris has pivoted itself for new growth & opportunity through investments & management interest in the fields of Clean Energy, Venture Capital & Incubators.
Our genesis dates to 1999 with Claris Lifesciences, a healthcare company specialising in niche & high entry barrier businesses with focus on infusions and specialty injectables. Claris was one of the largest pure-play sterile generic injectable companies in India with approvals from the most stringent regulatory bodies in the world, like US FDA, MHRA (UK), and TGA (Australia), among others. At its peak, the infusions business had more than 50% market share in the IV fluids segment, in the regions and product SKUs where present.
In a span of two decades, the company created nearly billion-dollar valuation, established world-class integrated business model, built presence in over 100 countries, had a team of over 4,000, and was listed on the Bombay Stock Exchange. Claris exited healthcare in 2017, after sale of injectables business to Baxter Inc., and the infusions business to Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. Ltd.
Besides winning several prestigious industry awards, Claris prides itself on being the recipient of ‘India’s Best Companies to Work For’ award from Great Place to Work, India and The Economic Times, 8 years in a row.
Parallel to striving for excellence, Claris serves as a socially responsible organisation, fulfilling goals beyond business commitments. We support and encourage various social causes and focus our capabilities on creating opportunities in the sports and fitness sector, building ecosystems for business and entrepreneurship, and turning the spotlight on art & culture.
Powered by experience in building large scale global healthcare businesses from scratch, efficiently & quickly, Claris has pivoted itself for new growth & opportunity through investments & management interest in the fields of Clean Energy, Venture Capital & Incubators.
Our genesis dates to 1999 with Claris Lifesciences, a healthcare company specialising in niche & high entry barrier businesses with focus on infusions and specialty injectables. Claris was one of the largest pure-play sterile generic injectable companies in India with approvals from the most stringent regulatory bodies in the world, like US FDA, MHRA (UK), and TGA (Australia), among others. At its peak, the infusions business had more than 50% market share in the IV fluids segment, in the regions and product SKUs where present.
In a span of two decades, the company created nearly billion-dollar valuation, established world-class integrated business model, built presence in over 100 countries, had a team of over 4,000, and was listed on the Bombay Stock Exchange. Claris exited healthcare in 2017, after sale of injectables business to Baxter Inc., and the infusions business to Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. Ltd.
Besides winning several prestigious industry awards, Claris prides itself on being the recipient of ‘India’s Best Companies to Work For’ award from Great Place to Work, India and The Economic Times, 8 years in a row.
Parallel to striving for excellence, Claris serves as a socially responsible organisation, fulfilling goals beyond business commitments. We support and encourage various social causes and focus our capabilities on creating opportunities in the sports and fitness sector, building ecosystems for business and entrepreneurship, and turning the spotlight on art & culture.
Location: India, Gujarat, Ahmedabad
Founded date: 1999
Investors 1
| Date | Name | Website |
| - | Signet Hea... | signetheal... |
Mentions in press and media 4
| Date | Title | Description |
| 22.05.2015 | Claris Lifesciences Limited Audited Financial Results for the Quarter and Financial Year (Fifteen Months) Ended 31st March 2015 | Ahmedabad, Gujarat, India Claris Lifesciences Ltd. (CLL) today announced its Audited Financial Results for the quarter and financial year (fifteen months] ended 31st March 2015 at its board meeting held at its registered office in Ahmedabad... |
| 10.11.2014 | Claris Lifesciences Limited Un-Audited Financial Results for the Quarter Ended 30th September 2014 | New Delhi, Delhi, India Claris Lifesciences Ltd. (CLL) announced its quarterly un-audited financial results for the quarter ended 30th September 2014 at its board meeting held at its registered office in Ahmedabad. On the 31st of October, a... |
| 21.08.2014 | Claris Lifesciences Receives MHRA Approval for New Plant | India Claris Lifesciences Limited (Company) has today announced it has received the MHRA approval for its newly commissioned plant (Plant 2). This will help in enhancing capacities to grow in the regulated markets, especially the European U... |
| 12.08.2014 | Claris Lifesciences Limited Un-audited Financial Results for the Quarter Ended 30th June 2014 | New Delhi, Delhi, India Claris Lifesciences Ltd. today announced its quarterly and half yearly un-audited financial results for the quarter and half year ended 30th June 2014 at its board meeting held at its registered office in Ahmedabad. ... |